Quantum Pharmics Company Profile
✉ Email this page to a colleague
What is the competitive landscape for QUANTUM PHARMICS
QUANTUM PHARMICS has sixty-three approved drugs.
Summary for Quantum Pharmics
| US Patents: | 0 |
| Tradenames: | 25 |
| Ingredients: | 23 |
| NDAs: | 63 |
Drugs and US Patents for Quantum Pharmics
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quantum Pharmics | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 088510-001 | Jan 31, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Quantum Pharmics | NYSTATIN | nystatin | TABLET;VAGINAL | 062509-001 | Apr 3, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Quantum Pharmics | BENZTROPINE MESYLATE | benztropine mesylate | TABLET;ORAL | 088514-001 | Jan 31, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
